Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Graviti Pharmaceuticals

    Client Virtual Booth

    GRAVITI PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Graviti Pharmaceuticals
    india-flag Flag
    Country
    Country
    India
    Address
    Address
    Plot Number 64, Nagarjuna Hills, Panjagutta, Hyderabad – 500 084, Telangana
    Telephone
    Telephone
    040 6815 5555
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.gravitipharma.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Graviti Pharma`s Generic Famotidine Receives Approval in the U.S.
    Graviti Pharma`s Generic Famotidine Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218461

    FDA
    14 Mar 2024
    Share Share
    Graviti's Generic Baclofen Receives Approval in the U.S.
    Graviti's Generic Baclofen Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217788

    FDA
    10 Jan 2024
    Share Share
    Graviti's Generic Hydroxyzine Hydrochloride Receives Approval in the U.S.
    Graviti's Generic Hydroxyzine Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217652

    FDA
    17 Aug 2023
    Share Share
    Graviti Pharmaceuticals' Generic Chlorzoxazone Receives Approval in the U.S.
    Graviti Pharmaceuticals' Generic Chlorzoxazone Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216925

    FDA
    09 Aug 2023
    Share Share
    Graviti's Generic Gabapentin Receives Approval in the U.S.
    Graviti's Generic Gabapentin Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217995

    FDA
    19 Jul 2023
    Share Share
    Graviti's Generic Furosemide Receives Approval in the U.S.
    Graviti's Generic Furosemide Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216629

    FDA
    17 Oct 2022
    Share Share
    Graviti Pharm`s Generic Choline Ranolazine Receives Approval in US
    Graviti Pharm`s Generic Choline Ranolazine Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212889

    FDA
    30 Jan 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-2024-05-06

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search